LOUISVILLE, Ky., July 18, 2023 (Newswire.com) - Baptist Health, Kentucky's largest health system, has announced a partnership with Chronicled's MediLedger to pioneer a new era of contract management within healthcare.

Baptist Health is the inaugural hospital system to utilize MediLedger's groundbreaking blockchain technology solution to ensure pharmaceuticals bought by the nine-hospital system are correctly priced.

"With more than 400 locations that purchase pharmaceuticals, and over 40,000 pharmaceuticals available for purchase on each of those accounts, Baptist Health was looking for a turnkey solution to smooth the lines of communication and ensure we receive the correct negotiated contracted prices for pharmaceutical products in a timely fashion," said Thomas Matanich, system director of pharmacy contract management for Baptist Health.

Matanich said the current process is cumbersome, opaque, and often resulted in lengthy claims reprocessing work, creating cash flow issues.

"The industry needed a real-time environment for all parties to partner and eliminate costs associated with claims rework," Matanich added, "Mediledger and blockchain technology will allow us to collaborate in real-time with the Premier group purchasing organization, manufacturers, and wholesalers to identify price discrepancies at the beginning of the purchasing process, addressing any potential pricing discrepancy before a purchase is made and subsequent claims rework required."

MediLedger's platform transforms the traditional approach to managing contracts, proactively identifying discrepancies and automating alignment between trading partners and customers. With MediLedger, contracts among group purchasing organizations, manufacturers, wholesalers, and health systems such as Baptist Health are synchronized, maintaining accurate pricing across all sites. This pricing transparency, coupled with the ability to publish rosters directly to all parties involved, ensures up-to-date and accurate information sharing, leading to more informed decision-making.

"Our partnership with MediLedger reflects our commitment to innovation and operational excellence," said Nilesh Desai, Baptist Health's Chief Pharmacy Officer. "Their blockchain solution will enable us to streamline processes, improve service delivery, and play an even more significant role in contract negotiations and pricing processes which, in turn, will have a positive impact on patient cost and care."

The decision to partner with MediLedger reinforces Baptist Health's commitment to enhanced transparency with resulting optimized revenue, improved cash flow, and increased influence and decision-making power within the industry.

"We are thrilled to collaborate with Baptist Health, a true trailblazer in the healthcare sector," added Vinod Lakhani, CEO of MediLedger. "Their dedication to innovation aligns with our vision at MediLedger and we are excited to support Baptist Health as they continue to shape the future of healthcare. Adding hospital systems to MediLedger network will expand the value of the network to all its participants. We are confident that Baptist Health's participation in the MediLedger network will help to accelerate the adoption of the MediLedger network in the life sciences sector. Together, we can help to make transactions more efficient and transparent for the life science industry."

About Baptist Health

Founded in 1924 in Louisville, Kentucky, Baptist Health is a full-spectrum health system dedicated to improving the health of the communities it serves. The Baptist Health family consists of nine hospitals, employed and independent physicians, and more than 450 points of care, including outpatient facilities, physician practices and services, urgent care clinics, outpatient diagnostic and surgery centers, home care, fitness centers, and occupational medicine and physical therapy clinics.

Baptist Health's eight owned hospitals include more than 2,300 licensed beds in Corbin, Elizabethtown, La Grange, Lexington, Louisville, Paducah, Richmond and New Albany, Indiana. Baptist Health also operates the 410-bed Baptist Health Deaconess Madisonville in Madisonville, Kentucky in a joint venture with Deaconess Health System based in Evansville, Indiana. Baptist Health employs more than 22,500 people in Kentucky and surrounding states.

Baptist Health is the first health system in the U.S. to have all of its hospitals recognized by the American Nursing Credentialing Center with either a Magnet® or Pathway to Excellence® designation for nursing excellence.

Baptist Health's employed provider network, Baptist Health Medical Group, has more than 1,650 providers offering care in 74 specialties, including more than 780 physicians and more than 870 advanced practice clinicians. Baptist Health's physician network also includes more than 2,000 independent physicians. 

Learn more at BaptistHealth.com.

About MediLedger

MediLedger, administered by Chronicled, is an industry pioneer, offering blockchain-based solutions for the healthcare industry. Their decentralized network enables seamless, transparent communication among healthcare providers, enhancing patient safety, improving healthcare outcomes, and optimizing operations. Learn more here.

Baptist Health Media Contact:

Kit Fullenlove Barry
Director, Public Relations
Baptist Health
Louisville, Kentucky
502.253.5367
[email protected]

MediLedger Media Contact:

Juli Cooper
Head of Marketing
Chronicled
San Francisco, CA
[email protected]

Contact Information:
Kit Fullenlove Barry
Director, Public Relations
[email protected]
502.253.5367

Juli Cooper
Head of Marketing
[email protected]




Original Source: Baptist Health Partners With MediLedger to Ensure Correct Pricing via Contract Management

The company pioneered and received clearance earlier this year on the world's first 3D printed, fully interconnected porous PEEK interbody.

HUNTSVILLE, Ala., July 18, 2023 (Newswire.com) - Curiteva, a privately held technology and manufacturing company based in Huntsville, AL announces the commercial launch of its Inspire Porous PEEK HA^FUSE Cervical Interbody System. 

The company pioneered and received clearance earlier this year on the world's first 3D printed, fully interconnected porous PEEK interbody. This extraordinary advancement in additive manufacturing of polymers creates a new classification of interbody fusion devices with optimal characteristics for bony healing.

"We are very pleased with the positive surgeon feedback we received during our limited release in April. Now with full commercialization, the team is excited to see continued adoption of our novel 3D printed porous PEEK implant with HA^FUSE Technology," stated Mark Mohlman, EVP. "This launch is just the beginning as we continue to develop our additional lumbar portfolio scheduled for launch in 2024."

The Inspire platform is manufactured with a proprietary, patented Fused Filament Fabrication 3D printer designed, programmed, and built by Curiteva. This ground-breaking additive process produces a fully interconnected and integrated porous structure traversing the entire implant to promote osseointegration, improve radiographic assessment, and deliver superior biomechanics. The first-to-market combination of the HA^FUSE nanotechnology surface treatment and novel porous PEEK structure creates a hydrophilic, bioactive environment for cell attachment, proliferation, and healing in pre-clinical animal and in vitro studies.

"Curiteva received FDA clearance in February, initiated our alpha release in April and scaled to a commercial launch in July. I am proud of the entire Curiteva team for another milestone achievement and grateful to our surgeons and distributors for their patience and support," commented CEO Mike English. 

The Inspire technology will be featured at the NASS meeting later this year. 

Curiteva is a privately held technology and manufacturing company dedicated to advancing spine surgery and improving clinical outcomes by partnering with providers and suppliers to deliver innovative and intuitive implant systems to the market. Our business is founded on a commitment to building world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering novel technology to meet the evolving needs of our customers and the patients they serve. 

Contact Information:
Kristen Kyzer
Director of Business Development
[email protected]
256.213.1057


Original Source: Curiteva Announces World's First 3D Printed PEEK Device With Regulatory Clearance Reaches Full Commercial Launch in the United States

FemAid Device Offers Relief from Female Incontinence

LOS ANGELES, July 18, 2023 (Newswire.com) - Richard Langson Founder of FemAid , a pioneering medical device company dedicated to empowering women's health, is proud to announce the completion of prototyping and the filing of its patent. The FemAid device stops leakage utilizing a patent-pending check valve device, which is non-surgically placed in the woman's urethra. It is fully adjustable to fulfill a women's personal needs. It interrupts the flow of urine until activated by the woman applying pressure to her bladder. This overpowers the check valve and lets the urine flow. The device can be inserted or removed at any time by the woman utilizing the supplied insertion/removal stylist.

The FemAid device is economical and easy to use. It is made of body-friendly Teflon material and is designed for maximum comfort. It comes sealed with antibacterial numbing ointment to minimize infection and pain, with a personal applicator included. The woman can insert the device herself or have a medical practitioner insert it for her. 

Female Incontinence is a common and often overlooked health concern that affects over one billion women worldwide, causing discomfort, embarrassment and diminished quality of life. FemAid is committed to providing women with a solution that addresses this pervasive issue, offering a non-invasive and drug-free alternative for those seeking relief. 

The completion of the prototyping phase signifies a significant advancement for FemAid. Through tireless research and development efforts, the company has engineered a novel device specifically designed to target the root cause of urinary incontinence in women and a breakthrough in treatment options. FemAid is actively seeking strategic investors who share their vision and passion for improving women's lives affected by urinary incontinence. By partnering with strategic investors, the company aims to accelerate the development process and bring this innovative device to market as soon as possible, benefiting women globally.

The next steps for FemAid involve raising development funding and navigating the FDA registration process. The company remains dedicated to adhering to the highest standards of safety and efficacy, ensuring that its devices meet all regulatory requirements before becoming commercially available to women in need.

For more information about FemAid and their revolutionary non-surgical, non-drug incontinence devise, please contact:

Richard Langson, Founder, FemAid

775 720-6670

Contact Information:
Richard Langson
Founder
[email protected]
17757206670


Original Source: FemAid Addresses Female Incontinence

A Leader in Developing Cutting-Edge Hospital Applications, M2 Information Systems Launches IRIS Family Messaging to Help Streamline Communication & Foster Stronger Connections Between Patients, Their Families & Healthcare Professionals

EDMONDS, Wash., July 18, 2023 (Newswire.com) - Seattle-based M2 Information Systems introduces an innovative family messaging platform, enhancing the patient-care continuum by bridging communication gaps between healthcare professionals, patients, and their families.

M2 Information Systems, a leader in developing cutting-edge hospital applications, today announces the launch of its newest offering, the IRIS Family Messaging. This groundbreaking product represents a significant step in streamlining communication and fostering stronger connections between patients, their families, and healthcare professionals.

For nearly three decades, M2 Information Systems has pioneered technology solutions that have transformed the medical sector, ranging from PC-based order management systems to clinical workflow applications. Leveraging its vast expertise, the company created the first hospital web-based clinical systems and has since established itself as a trailblazer in the digital health technology landscape.

Today, that pioneering spirit continues with the launch of IRIS Family Messaging. Building on the success of MicroBloggingMD (MBMD), IRIS Family Messaging has been developed to empower patients and families by bridging communication gaps in hospital settings. This tool will update families on their loved one's condition, treatments, and progress, regardless of physical distances or time zones.

Beyond patient and family benefits, IRIS Family Messaging also promises substantial improvements to the workflows of hospital staff, boosting their productivity and the ability to provide the highest level of patient care. By reducing communication barriers, staff can focus on critical care delivery, boosting job satisfaction. Furthermore, by fostering a collaborative environment, IRIS Family Messaging could play a pivotal role in reducing errors, streamlining administrative duties, and ultimately, elevating the standard of healthcare services. 

"M2 Information Systems is committed to creating innovative solutions that address the complex challenges faced by today's healthcare industry," said Tom Wilkes, CEO of M2 Information Systems. "With IRIS Family Messaging, we are taking a significant step towards ensuring that the family is not just a spectator but an integral part of the patient's care team."

IRIS Family Messaging features include real-time updates, secure data encryption, a user-friendly interface, and 24/7 access, making it not just a tool for communication but an extension of care. It underscores the company's ongoing commitment to enhancing patient engagement and improving outcomes through technology.

To learn more about IRIS Family Messaging and other innovative solutions offered by M2 Information Systems, visit www.m2IRIS.com. 

About M2 Information Systems, Inc.

M2 Information Systems, Inc., based in Seattle, has been at the forefront of developing, installing, and supporting hospital applications across the U.S. for the past 28 years. Since its inception in 1983, M2 has focused on creating advanced solutions that improve clinical workflow in larger facilities and lead the transition from paper-based to digital systems. 

For Press Inquiries:
Regan Wynne
[email protected]

Contact Information:
Regan Wynne
Drector of Marketing
[email protected]
8186362323


Original Source: M2 Information Systems Launches Revolutionary IRIS Family Messaging: Reinventing Communication in Healthcare Settings